N. prodotti: 0
Totale ordine: € 0,00
Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,632
Online ISSN 1827-191X
Bakir I. 1, Casselman F. 1, De Geest R. 1, Wellens F. 1, Foubert L. 2,Degrieck I. 1, Van Praet F. 1, Vermeulen Y. 1, Vanermen H. 1
1 Department of Cardiovascular and Thoracic Surgery, OLV Clinic, Aalst, Belgium
2 Department of Anesthesiology and Critical Care Medicine, OLV Clinic, Aalst, Belgium
Aim. Minimally invasive aortic valve surgery has been studied widely with outcomes comparable or better than standard sternotomy. We recently reported on decreased blood loss, cross clamp time and length of hospital stay when compared to conventional full sternotomy. We expanded the indication to aortic root surgery and report here our 8 years experience.
Methods. From December 1997 to November 2005, 35 patients (mean age 51.3±15 years) underwent aortic root replacement, through a partial upper J-sternotomy. A homograft was implanted in 26 (74.3%) patients; the remainder received a valved (4 bioprosthesis, 5 mechanical) conduit. Mean preoperative euroscore was 7±2.7 and mean predicted mortality was 11.5±13.8%. Mean and median follow-up time was 51±31 and 66 months, respectively.
Results. Mean aortic cross clamp and cardiopulmonary bypass time were 126±25 and 182±61 min respectively. Revision for bleeding was necessary in 1 (2.9%) patient. Mean extubation time was 10.4±4.8 hours. No postoperative strokes occurred. Intensive care unit stay ranged from 1 to 42 days (2.7±7.4 days, median 1). There were 3 (8.5%) early deaths (sepsis, multi-organ failure and low cardiac output) and 2 late non-cardiac deaths. Hospital morbidity included acute renal failure (n=3), pacemaker implantation (n=3), and prolonged ventilation (n=3). Eleven (31.4%) patients experienced atrial fibrillation. No other reoperations were performed. Actuarial survival at 99 months was 74.4% (n=30).
Conclusion. Our results indicate that minimally invasive aortic root replacement is a challenging but feasible procedure with a lower observed mortality than predicted mortality. We continue to perform this procedure in good risk patients.